Technology Assessment, Medical Informatics, and the Loss of Clinical Freedom - Assessing Medical Technologies, Committee for Evaluating Medical Technologies in Clinical Use, Division of Health Sciences Policy, Division of Health Promotion and Disease Prevention, Institute of Medicine, Washington, D.C., National Academy Press, 1985, 573 pp.

1988 ◽  
Vol 4 (1) ◽  
pp. 153-158 ◽  
Author(s):  
John P. Bunker ◽  
Jinnet Fowles
1996 ◽  
Vol 3 (1) ◽  
pp. 6-23 ◽  
Author(s):  
Lauren Leveton ◽  
Patricia Mrazek ◽  
Michael Stoto

A group convened by the Board on Health Promotion and Disease Prevention of the Institute of Medicine (IOM), in conjunction with the Board on Children and Families of the Commission on Behavioral Social Sciences and Education and the IOM, met to assess the state of the art and science regarding social marketing concepts and strategies in adolescent and minority populations. In summary, the group recognized the importance of promoting healthful behaviors in these populations, but the effectiveness of implementing social marketing approaches to facilitate and sustain behavioral change specific to these two populations remains disappointingly unproven. Despite two decades of empirical research in this area, there remains no firm foundation of scientific theory and empirical research to understand and validate the efficacy of various social marketing programs for these populations. Several research questions emerged from the review of the papers on social marketing in adolescent and minority populations. The Board on Health Promotion and Disease Prevention suggests that these research issues be addressed in future social marketing studies.


1991 ◽  
Vol 7 (3) ◽  
pp. 361-364
Author(s):  
Jeffrey P. Koplan ◽  
Felix F. Gutzwiller

The articles in this issue of the International Journal of Technology Assessment in Health Care (IJTAHC) have explored the assessment of preventive health technologies. When considered together, these technologies provide an interesting contrast with the health care technologies that are usually evaluated on these pages. Disease prevention and its twin, health promotion, are usually practiced on a well population. Thus, many persons have the technology applied to them but only a fraction of these would have acquired the condition being prevented. Often the intervention is applied to populations rather than to individuals. The unit cost for preventive technologies is usually far less than that of diagnostic or therapeutic technologies. However, when multiplied by the larger population to be involved in the prevention program, the total costs can be considerable. In concluding this section on prevention, we would like to examine some of the larger areas of difference between preventive and other health technologies illustrated by the papers assembled here.


2011 ◽  
Author(s):  
Shava Cureton ◽  
LaShawn Hoffman ◽  
David Collins ◽  
Lisa M. Goodin ◽  
Elizabeth Armstrong-Mensah

Sign in / Sign up

Export Citation Format

Share Document